© 2020 – 2022 AEA3 WEB | AEAƎ China News

WHO extends coverage of SINOVAC’s COVID-19 vaccine for 3-year-olds

WHO has expanded the use of Chinese manufacturer SINOVAC Biotech’s COVID-19 vaccine for children aged 3-17, making it the first and only vaccine on the WHO’s Emergency Use Listing (EUL) that has been recommended for children aged 3-4.

Related posts

Taiwan’s New Party vows to help improve relations


China launches communication satellite for Algeria


Decoupling viewed as risky bet for U.S.